CME FINANCIAL STATEMENTS

CME Group Inc — balance sheet, income statement and cash flow trends

CMECME Group Inc

🇺🇸 USA · US · Financial Services · Financial Data & Stock Exchanges

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue6.8 B $+7.5%

Gross Profit5.8 B $+7.4%

Operating Income4.4 B $+8.6%

EBITDA6 B $+15.9%

Net Income4.2 B $+17.0%

Peer Comparison· Financial Data & Stock Exchanges

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
CME	—	—	—	62.8%
DB1	—	—	—	27.1%
ENX	—	—	—	35.5%
X	—	—	—	16.5%
ASX	—	—	—	34.8%
Industry median	—	—	—	25.8%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity26.6 B $13%
Current Liabilities166 B $82%
Long-term Liabilities9.4 B $5%

Key Figures

YoY change

Total Assets202 B $+28.0%

Total Liabilities175.4 B $+34.1%

Total Equity26.6 B $-1.5%

Cash & ST Investments2.5 B $+65.6%

Total Debt3.4 B $+0.1%

Net Debt1 B $-48.8%

Peer Comparison· Financial Data & Stock Exchanges

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
CME	1.02	12.9%	0.15	13.2%
DB1	1.01	—	—	2.9%
ENX	6.03	72.2%	1.10	1.2%
X	2.35	44.1%	3.35	8.7%
ASX	1.20	293.1%	-0.75	24.4%
Industry median	1.20	59.2%	1.44	24.4%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
CME	1.02	12.9%	0.15	13.2%
MCO	1.16	244.3%	1.47	20.3%
ICE	1.01	71.0%	2.81	16.5%
SPGI	0.68	44.6%	1.49	51.3%
NDAQ	10.15	78.5%	2.79	44.1%
MSCI	0.86	-236.9%	3.10	-50.0%
Industry median	1.20	59.2%	1.44	24.4%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow4.4 B $+12.9%

Capital Expenditures91.1 M $+3.1%

Free Cash Flow4.3 B $+13.2%

Dividends Paid-4.1 B $-206.3%

Peer Comparison· Financial Data & Stock Exchanges

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
CME	65.4%	64.1%	1.3%	104.2%
DB1	54.7%	—	7.2%	201.5%
ENX	59.6%	54.1%	5.5%	167.8%
X	44.1%	36.1%	8.0%	267.6%
ASX	-1.9%	-13.3%	11.4%	-5.4%
Industry median	38.4%	35.1%	3.5%	144.1%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
CME	65.4%	64.1%	1.3%	104.2%
MCO	39.2%	38.0%	5.2%	123.6%
ICE	38.4%	34.9%	3.5%	128.1%
SPGI	36.5%	35.3%	1.1%	120.1%
NDAQ	27.6%	24.2%	3.4%	119.2%
MSCI	49.2%	47.4%	1.7%	120.7%
Industry median	38.4%	35.1%	3.5%	144.1%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CME

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
CME	—	—	—	62.8%
MCO	—	—	—	31.7%
ICE	—	—	—	30.0%
SPGI	—	—	—	30.4%
NDAQ	—	—	—	23.1%
MSCI	—	—	—	40.7%
Industry median	—	—	—	25.8%